한글목차

액체 산소 기기 세계 시장 규모는 2024년 62억 3,000만 달러로 예측 기간 동안 3.97%의 CAGR로 2030년에는 78억 7,000만 달러에 달할 것으로 예상됩니다.

액체 산소 기기 세계 시장에는 액체 산소를 저장하고 환자에게 공급하도록 설계된 다양한 의료기기가 포함됩니다. 이러한 기기는 호흡기질환 치료에 중요한 역할을 하며, 병원 환경과 재택의료 모두에서 널리 사용되고 있습니다.

시장 촉진요인

호흡기질환 증가

주요 시장 과제

규제 준수 및 품질 보증

주요 시장 동향

텔레헬스 통합

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 액체 산소 기기 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 유통 채널별(직접 판매, 간접 판매)
  • 용도별(병원, 외래 시설, 재택 케어, 기타)
  • 지역별
  • 기업별(2024)
• 제품 시장 맵
  • 유통 채널별
  • 최종 용도별
  • 지역별

제6장 북미의 액체 산소 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 액체 산소 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인

제8장 아시아태평양의 액체 산소 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국

제9장 남미의 액체 산소 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 액체 산소 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 인수합병
• 제품 출시

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제14장 경쟁 구도

• CAIRE Inc
• Cryofab Inc
• Koninklijke Philips NV
• Air Liquide SA
• Inogen Inc
• ErgoMed Inc.
• Taylor-Wharton International LLC

제14장 8 이노바라보

• 데빌 나사 헬스케어
• NTK 산소 전자 주식회사

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

영문목차

Global Liquid Oxygen Devices Market was valued at USD 6.23 billion in 2024 and is expected to reach USD 7.87 billion by 2030 with a CAGR of 3.97% during the forecast period. The Global Liquid Oxygen Devices Market encompasses a diverse range of medical equipment designed to store and deliver liquid oxygen to patients. These devices play a crucial role in the treatment of respiratory conditions and are widely used in both hospital settings and for home healthcare.

Key Market Drivers

Increasing Prevalence of Respiratory Diseases

Respiratory diseases have become a global health concern, affecting millions of people across the world. As the prevalence of respiratory conditions continues to rise, the demand for medical solutions, such as liquid oxygen devices, has surged.

Respiratory diseases encompass a broad spectrum of conditions, including chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and pulmonary fibrosis. They are characterized by symptoms like shortness of breath, wheezing, and coughing, which can significantly impact a patient's quality of life.

Environmental factors, such as air pollution, play a major role in the development of respiratory conditions. Prolonged exposure to pollutants, both indoors and outdoors, increases the risk of developing lung diseases. As industrialization and urbanization continue to expand, air quality concerns persist. Smoking is a leading cause of respiratory diseases, particularly COPD and lung cancer. Despite ongoing anti-smoking campaigns and regulations, tobacco use remains prevalent in many regions, contributing to the burden of respiratory conditions. The global population is aging, with a larger proportion of elderly individuals who are more susceptible to respiratory diseases. Aging is associated with a natural decline in lung function, making older adults more vulnerable to these conditions. Sedentary lifestyles, unhealthy diets, and obesity are additional risk factors for developing respiratory diseases. These lifestyle choices are increasingly common in both developed and developing countries.

Key Market Challenges

Regulatory Compliance and Quality Assurance

Ensuring that liquid oxygen devices meet stringent regulatory standards and quality assurance requirements is a significant challenge. Manufacturers must navigate complex and evolving regulations to maintain the safety and efficacy of their products. Failure to comply with these regulations can result in product recalls and legal consequences.

Key Market Trends

Telehealth Integration

The integration of telehealth and remote patient monitoring is becoming increasingly prevalent. This trend is set to impact the liquid oxygen devices market as healthcare providers use telehealth platforms to monitor and adjust oxygen therapy remotely, enhancing patient convenience and adherence to treatment.

Key Market Players

• CAIRE Inc.
• Cryofab Inc
• Koninklijke Philips N.V.
• Air Liquide SA
• Inogen Inc
• ErgoMed Inc.
• Taylor-Wharton International LLC
• Inova Labs
• DeVilbiss Healthcare
• NTK Oxygen Electronics Co. Ltd.

Report Scope:

In this report, the Global Liquid Oxygen Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Liquid Oxygen Devices Market, By Distribution Channel:

• Direct Sales
• Indirect Sales

Liquid Oxygen Devices Market, By End Use:

• Hospitals
• Outpatient Facilities
• Homecare
• Others

Liquid Oxygen Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Liquid Oxygen Devices Market.

Available Customizations:

Global Liquid Oxygen Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Liquid Oxygen Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Distribution Channel (Direct Sales, Indirect Sales)
  • 5.2.2. By End Use (Hospitals, Outpatient Facilities, Homecare, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Distribution Channel
  • 5.3.2. By End Use
  • 5.3.3. By Region

6. North America Liquid Oxygen Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Distribution Channel (Direct Sales, Indirect Sales)
  • 6.2.2. By End Use (Hospitals, Outpatient Facilities, Homecare, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Liquid Oxygen Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Distribution Channel
      • 6.3.1.2.2. By End Use
  • 6.3.2. Canada Liquid Oxygen Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Distribution Channel
      • 6.3.2.2.2. By End Use
  • 6.3.3. Mexico Liquid Oxygen Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Distribution Channel
      • 6.3.3.2.2. By End Use

7. Europe Liquid Oxygen Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Distribution Channel (Direct Sales, Indirect Sales)
  • 7.2.2. By End Use (Hospitals, Outpatient Facilities, Homecare, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Liquid Oxygen Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Distribution Channel
      • 7.3.1.2.2. By End Use
  • 7.3.2. United Kingdom Liquid Oxygen Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Distribution Channel
      • 7.3.2.2.2. By End Use
  • 7.3.3. France Liquid Oxygen Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Distribution Channel
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Liquid Oxygen Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Distribution Channel
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Liquid Oxygen Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Distribution Channel
      • 7.3.5.2.2. By End Use

8. Asia-Pacific Liquid Oxygen Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Distribution Channel (Direct Sales, Indirect Sales)
  • 8.2.2. By End Use (Hospitals, Outpatient Facilities, Homecare, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Liquid Oxygen Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Distribution Channel
      • 8.3.1.2.2. By End Use
  • 8.3.2. Japan Liquid Oxygen Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Distribution Channel
      • 8.3.2.2.2. By End Use
  • 8.3.3. India Liquid Oxygen Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Distribution Channel
      • 8.3.3.2.2. By End Use
  • 8.3.4. Australia Liquid Oxygen Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Distribution Channel
      • 8.3.4.2.2. By End Use
  • 8.3.5. South Korea Liquid Oxygen Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Distribution Channel
      • 8.3.5.2.2. By End Use

9. South America Liquid Oxygen Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Distribution Channel (Direct Sales, Indirect Sales)
  • 9.2.2. By End Use (Hospitals, Outpatient Facilities, Homecare, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Liquid Oxygen Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Distribution Channel
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Liquid Oxygen Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Distribution Channel
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Liquid Oxygen Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Distribution Channel
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Liquid Oxygen Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Distribution Channel (Direct Sales, Indirect Sales)
  • 10.2.2. By End Use (Hospitals, Outpatient Facilities, Homecare, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Liquid Oxygen Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Distribution Channel
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Liquid Oxygen Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Distribution Channel
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Liquid Oxygen Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Distribution Channel
      • 10.3.3.2.2. By End Use
  • 10.3.4. Kuwait Liquid Oxygen Devices Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Distribution Channel
      • 10.3.4.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. CAIRE Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product Offerings
  • 14.1.4. Recent Developments
  • 14.1.5. Financials (As Reported)
  • 14.1.6. Key Personnel
  • 14.1.7. SWOT Analysis
• 14.2. Cryofab Inc
• 14.3. Koninklijke Philips NV
• 14.4. Air Liquide SA
• 14.5. Inogen Inc
• 14.6. ErgoMed Inc.
• 14.7. Taylor-Wharton International LLC

14.8 Inova Labs

• 14.9. DeVilbiss Healthcare
• 14.10. NTK Oxygen Electronics Co. Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer